459 related articles for article (PubMed ID: 28875969)
21. Pancreatic lesions in von Hippel-Lindau syndrome: report of a case.
Künzli BM; Shrikhande SV; Büchler MW; Friess H
Surg Today; 2004; 34(7):626-9. PubMed ID: 15221562
[TBL] [Abstract][Full Text] [Related]
22. When to look for Von Hippel-Lindau disease in gastroenteropancreatic neuroendocrine tumors?
Ling H; Cybulla M; Schaefer O; Arnold C; Schories M; Neumann HP
Neuroendocrinology; 2004; 80 Suppl 1():39-46. PubMed ID: 15477716
[TBL] [Abstract][Full Text] [Related]
23. Von Hippel-Lindau: how a rare disease illuminates cancer biology.
Richard S; Gardie B; Couvé S; Gad S
Semin Cancer Biol; 2013 Feb; 23(1):26-37. PubMed ID: 22659535
[TBL] [Abstract][Full Text] [Related]
24. von Hippel Lindau syndrome presenting as obstructive jaundice with involvement of pancreas in two siblings.
Issar SK; Kumar N; Sachdeva AK; Jain P; Puri SK
Trop Gastroenterol; 1996; 17(2):30-2. PubMed ID: 8783974
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic neuroendocrine tumours in patients with von Hippel-Lindau disease.
Zwolak A; Świrska J; Tywanek E; Dudzińska M; Tarach JS; Matyjaszek-Matuszek B
Endokrynol Pol; 2020; 71(3):256-259. PubMed ID: 32797472
[TBL] [Abstract][Full Text] [Related]
26. Von Hippel-Lindau syndrome. A pleomorphic condition.
Friedrich CA
Cancer; 1999 Dec; 86(11 Suppl):2478-82. PubMed ID: 10630173
[TBL] [Abstract][Full Text] [Related]
27. Management recommendations for pancreatic manifestations of von Hippel-Lindau disease.
Laks S; van Leeuwaarde R; Patel D; Keutgen XM; Hammel P; Nilubol N; Links TP; Halfdanarson TR; Daniels AB; Tirosh A;
Cancer; 2022 Feb; 128(3):435-446. PubMed ID: 34735022
[TBL] [Abstract][Full Text] [Related]
28. Von Hippel-Lindau disease: molecular pathological basis, clinical criteria, genetic testing, clinical features of tumors and treatment.
Shuin T; Yamasaki I; Tamura K; Okuda H; Furihata M; Ashida S
Jpn J Clin Oncol; 2006 Jun; 36(6):337-43. PubMed ID: 16818478
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic lesions in von Hippel-Lindau disease.
Mukhopadhyay B; Sahdev A; Monson JP; Besser GM; Reznek RH; Chew SL
Clin Endocrinol (Oxf); 2002 Nov; 57(5):603-8. PubMed ID: 12390333
[TBL] [Abstract][Full Text] [Related]
30. Nervous system involvement in von Hippel-Lindau disease: pathology and mechanisms.
Vortmeyer AO; Falke EA; Gläsker S; Li J; Oldfield EH
Acta Neuropathol; 2013 Mar; 125(3):333-50. PubMed ID: 23400300
[TBL] [Abstract][Full Text] [Related]
31. Pheochromocytoma as the first manifestation of von Hippel-Lindau disease.
Richard S; Beigelman C; Duclos JM; Fendler JP; Plauchu H; Plouin PF; Resche F; Schlumberger M; Vermesse B; Proye C
Surgery; 1994 Dec; 116(6):1076-81. PubMed ID: 7985090
[TBL] [Abstract][Full Text] [Related]
32. [Pancreatic lesions in von Hippel-Lindau disease].
Terris B; Hammel P
Ann Pathol; 2000 Mar; 20(2):124-9. PubMed ID: 10740007
[No Abstract] [Full Text] [Related]
33. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
Jensen RL; Gillespie D; House P; Layfield L; Shelton C
J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
[TBL] [Abstract][Full Text] [Related]
34. Differential grading of endolymphatic sac tumor extension by virtue of von Hippel-Lindau disease status.
Bambakidis NC; Megerian CA; Ratcheson RA
Otol Neurotol; 2004 Sep; 25(5):773-81. PubMed ID: 15354010
[TBL] [Abstract][Full Text] [Related]
35. Guidelines for surveillance of patients with von Hippel-Lindau disease: Consensus statement of the International VHL Surveillance Guidelines Consortium and VHL Alliance.
Daniels AB; Tirosh A; Huntoon K; Mehta GU; Spiess PE; Friedman DL; Waguespack SG; Kilkelly JE; Rednam S; Pruthi S; Jonasch EA; Baum L; Chahoud J;
Cancer; 2023 Oct; 129(19):2927-2940. PubMed ID: 37337409
[No Abstract] [Full Text] [Related]
36. Clear cell endocrine pancreatic tumor mimicking renal cell carcinoma: a distinctive neoplasm of von Hippel-Lindau disease.
Hoang MP; Hruban RH; Albores-Saavedra J
Am J Surg Pathol; 2001 May; 25(5):602-9. PubMed ID: 11342771
[TBL] [Abstract][Full Text] [Related]
37. Histopathology and molecular genetics of multiple cysts and microcystic (serous) adenomas of the pancreas in von Hippel-Lindau patients.
Mohr VH; Vortmeyer AO; Zhuang Z; Libutti SK; Walther MM; Choyke PL; Zbar B; Linehan WM; Lubensky IA
Am J Pathol; 2000 Nov; 157(5):1615-21. PubMed ID: 11073821
[TBL] [Abstract][Full Text] [Related]
38. [Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)].
Richard S; Giraud S; Beroud C; Caron J; Penfornis F; Baudin E; Niccoli-Sire P; Murat A; Schlumberger M; Plouin PF; Conte-Devolx B
Ann Endocrinol (Paris); 1998; 59(6):452-8. PubMed ID: 10189987
[TBL] [Abstract][Full Text] [Related]
39. Late recurrence after surgical resection of a pancreatic tumor in von Hippel-Lindau disease.
Corleto VD; Cotesta D; Petramala L; Panzuto F; Pagnini C; Masoni L; Verrienti A; Delle Fave G; Filetti S; Letizia C
JOP; 2009 Sep; 10(5):562-5. PubMed ID: 19734639
[TBL] [Abstract][Full Text] [Related]
40. Genetic study of a large Chinese kindred with von Hippel-Lindau disease.
Huang YR; Zhang J; Wang JD; Fan XD
Chin Med J (Engl); 2004 Apr; 117(4):552-7. PubMed ID: 15109448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
